Together, we identify several hypoxia-induced ADC target proteins, CXADR, CD47, CD81, BSG, and FXYD6, and provide proof-of-concept evidence that TS-MAP can address the distinct hypoxic adaptations observed across GBM cultures from individual tumors. The gene discussed is CD47; the disease is glioblastoma.